The effect of SETD2 mutation (mts) on histone 3 lysine 36 trimethylation (H3K36me3) and correlation with clinical outcome in patients (pts) with metastatic clear cell renal cell carcinoma (ccRCC) enrolled in COMPARZ Meeting Abstract

  

Authors:	Ho, T. H.; Choueiri, T. K.; D'Amelio, A.; Hsieh, J.; De Souza, P. L.; Deen, K. C.; Langmuir, P. B.; Liu, Y.; Motzer, R. J.
Abstract Title:	The effect of SETD2 mutation (mts) on histone 3 lysine 36 trimethylation (H3K36me3) and correlation with clinical outcome in patients (pts) with metastatic clear cell renal cell carcinoma (ccRCC) enrolled in COMPARZ
Meeting Title:	50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	15 Suppl.
Meeting Dates:	2014 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-05-20
Language:	English
ACCESSION:	WOS:000358613203388
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.15_suppl.4583
Notes:	Meeting Abstract: 4583 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80929